Due to this fact, the aim of the study was to verify the expression of gene NRXN1 at the mRNA and protein level in patients suffering from depression versus healthy controls, as well as to search for clinical variables related to expression of the analyzed gene. This evidence concerns the gene NRXN1 and depressive disorder.